Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Core Binding Factor Alpha 2 Subunit | 4 | 2023 | 40 | 1.880 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2023 | 354 | 0.700 |
Why?
|
| Leukemia | 1 | 2023 | 387 | 0.620 |
Why?
|
| Ubiquitination | 2 | 2018 | 173 | 0.570 |
Why?
|
| Repressor Proteins | 5 | 2024 | 760 | 0.530 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2017 | 236 | 0.440 |
Why?
|
| Carrier Proteins | 1 | 2018 | 993 | 0.390 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2021 | 544 | 0.270 |
Why?
|
| Protein Stability | 2 | 2018 | 165 | 0.260 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2024 | 21 | 0.220 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2022 | 614 | 0.210 |
Why?
|
| Okadaic Acid | 1 | 2023 | 12 | 0.200 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 81 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2024 | 406 | 0.180 |
Why?
|
| Leukemia, Myeloid | 2 | 2020 | 80 | 0.180 |
Why?
|
| RUNX1 Translocation Partner 1 Protein | 2 | 2018 | 2 | 0.170 |
Why?
|
| Mutation | 3 | 2024 | 6099 | 0.160 |
Why?
|
| Homeodomain Proteins | 2 | 2020 | 555 | 0.150 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2019 | 18 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2020 | 113 | 0.150 |
Why?
|
| Cell Self Renewal | 1 | 2019 | 48 | 0.150 |
Why?
|
| Cytoplasm | 1 | 2019 | 249 | 0.140 |
Why?
|
| Erythroid Cells | 1 | 2018 | 23 | 0.140 |
Why?
|
| Methyltransferases | 1 | 2019 | 78 | 0.140 |
Why?
|
| K562 Cells | 1 | 2018 | 97 | 0.140 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4697 | 0.140 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 65 | 0.140 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2018 | 70 | 0.140 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2019 | 125 | 0.140 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 111 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 2323 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 533 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 587 | 0.130 |
Why?
|
| Atherosclerosis | 1 | 2024 | 948 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2018 | 336 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 484 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 722 | 0.110 |
Why?
|
| Calcium | 1 | 2019 | 1010 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2020 | 1928 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2024 | 4686 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1939 | 0.100 |
Why?
|
| NF-kappa B | 2 | 2024 | 440 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2020 | 2406 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3385 | 0.080 |
Why?
|
| Humans | 9 | 2024 | 131163 | 0.080 |
Why?
|
| Mice | 6 | 2024 | 18301 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3436 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2021 | 686 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 4738 | 0.070 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 317 | 0.060 |
Why?
|
| Animals | 6 | 2024 | 33912 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2024 | 56 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 1801 | 0.050 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2024 | 150 | 0.050 |
Why?
|
| Monocytes | 1 | 2024 | 335 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2465 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2024 | 190 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 3748 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2021 | 22 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2021 | 31 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 1 | 2020 | 64 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2020 | 61 | 0.040 |
Why?
|
| Macrophages | 1 | 2024 | 667 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 573 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 332 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 213 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2020 | 243 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 663 | 0.030 |
Why?
|
| Whole-Body Irradiation | 1 | 2018 | 60 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2018 | 46 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2020 | 594 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 373 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 819 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1239 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2024 | 3819 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2018 | 317 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 350 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 2326 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 801 | 0.030 |
Why?
|
| Gene Editing | 1 | 2018 | 238 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 589 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1483 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1827 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1586 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 2026 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4886 | 0.020 |
Why?
|
| Male | 3 | 2024 | 64957 | 0.020 |
Why?
|
| Female | 3 | 2021 | 70963 | 0.020 |
Why?
|